Feng Y, Lu Y. Advances in vitiligo: update on therapeutic targets. Front Immunol. 2022;13:986918. https://doi.org/10.3389/fimmu.2022.986918.
Article CAS PubMed PubMed Central Google Scholar
Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708–18. https://doi.org/10.1111/bjd.15199.
Article CAS PubMed Google Scholar
Monroe SM, Harkness KL. Major depression and its recurrences: life course matters. Ann Rev Clin Psychol. 2022;18:329–57. https://doi.org/10.1146/annurev-clinpsy-072220-021440.
Kussainova A, Kassym L, Akhmetova A, et al. Vitiligo and anxiety: A systematic review and meta-analysis. PLoS ONE. 2020;15(11):e0241445. https://doi.org/10.1371/journal.pone.0241445.
Article CAS PubMed PubMed Central Google Scholar
Picardi A, Pasquini P, Cattaruzza MS, et al. Stressful life events, social support, attachment security and alexithymia in vitiligo. A case-control study. Psychother Psychosom. 2003;72(3):150–8. https://doi.org/10.1159/000069731.
Article CAS PubMed Google Scholar
Papadopoulos L, Bor R, Legg C, Hawk JL. Impact of life events on the onset of vitiligo in adults: preliminary evidence for a psychological dimension in aetiology. Clin Exp Dermatol. 1998;23(6):243–8. https://doi.org/10.1046/j.1365-2230.1998.00384.x.
Article CAS PubMed Google Scholar
Osinubi O, Grainge MJ, Hong L, et al. The prevalence of psychological comorbidity in people with vitiligo: a systematic review and meta-analysis. Br J Dermatol. 2018;178(4):863–78. https://doi.org/10.1111/bjd.16049.
Article CAS PubMed Google Scholar
Cao C, Lin F, Jin R, et al. Anxiety-depression: a pivotal mental factor for accelerating disease progression and reducing curative effect in vitiligo patients. Front Psychol. 2024;15:1454947. https://doi.org/10.3389/fpsyg.2024.1454947.
Article PubMed PubMed Central Google Scholar
Rosenblat JD, Cha DS, Mansur RB, McIntyre RS. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2014;53:23–34. https://doi.org/10.1016/j.pnpbp.2014.01.013.
Article CAS PubMed Google Scholar
Wong ML, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry. 2008;13(8):800–12. https://doi.org/10.1038/mp.2008.59.
Article CAS PubMed PubMed Central Google Scholar
Slominski A, Wortsman J, Luger T, Paus R, Solomon S. Corticotropin releasing hormone and Proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev. 2000;80(3):979–1020. https://doi.org/10.1152/physrev.2000.80.3.979.
Article CAS PubMed Google Scholar
Slominski A, Zbytek B, Nikolakis G, et al. Steroidogenesis in the skin: implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107–23. https://doi.org/10.1016/j.jsbmb.2013.02.006.
Article CAS PubMed PubMed Central Google Scholar
Wu Y, Yang Y, Lin Y, et al. Emerging role of fibroblasts in vitiligo: a formerly underestimated rising star. J Invest Dermatol. 2024;144(8):1696–706. https://doi.org/10.1016/j.jid.2024.02.007.
Article CAS PubMed Google Scholar
Rani S, Bhardwaj S, Srivastava N, Sharma VL, Parsad D, Kumar R. Senescence in the lesional fibroblasts of non-segmental vitiligo patients. Arch Dermatol Res. 2017;309(2):123–32. https://doi.org/10.1007/s00403-016-1713-0.
Article CAS PubMed Google Scholar
Sibbald RG, Ayello EA. Psychophysiology: connecting skin, wounds, aging, and depression. Adv Skin Wound Care. 2021;34(8):399. https://doi.org/10.1097/01.asw.0000758600.40793.89.
Dong BQ, Liao ZK, Le Y et al. Acceleration of melanocyte senescence by the Proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy. Mech Ageing Dev. 2023;211:111779. https://doi.org/10.1016/j.mad.2023.111779
Article CAS PubMed Google Scholar
Bastonini E, Bellei B, Filoni A, Kovacs D, Iacovelli P, Picardo M. Involvement of non-melanocytic skin cells in vitiligo. Exp Dermatol. 2019;28(6):667–73. https://doi.org/10.1111/exd.13868.
Article CAS PubMed Google Scholar
Aliyu M, Zohora FT, Anka AU, et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. https://doi.org/10.1016/j.intimp.2022.109130.
Article CAS PubMed Google Scholar
Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295. https://doi.org/10.1101/cshperspect.a016295.
Article PubMed PubMed Central Google Scholar
Paldor M, Levkovitch-Siany O, Eidelshtein D, et al. Single-cell transcriptomics reveals a senescence-associated IL-6/CCR6 axis driving radiodermatitis. EMBO Mol Med. 2022;14(8):e15653. https://doi.org/10.15252/emmm.202115653.
Article CAS PubMed PubMed Central Google Scholar
Kawakami Y, Kajita A, Hasui KI, Matsuda Y, Iwatsuki K, Morizane S. Elevated expression of interleukin-6 (IL-6) and serum amyloid A (SAA) in the skin and the serum of recessive dystrophic epidermolysis Bullosa: skin as a possible source of IL-6 through Toll-like receptor ligands and SAA. Exp Dermatol. 2024;33(3):e15040. https://doi.org/10.1111/exd.15040.
Article CAS PubMed Google Scholar
Hu X, Qi C, Feng F, et al. Combining network pharmacology, RNA-seq, and metabolomics strategies to reveal the mechanism of cimicifugae Rhizoma—Smilax glabra Roxb herb pair for the treatment of psoriasis. Phytomed Int J Phytother Phytopharmacol. 2022;105:154384. https://doi.org/10.1016/j.phymed.2022.154384.
Forcina L, Franceschi C, Musarò A. The hormetic and hermetic role of IL-6. Ageing Res Rev. 2022;80:101697. https://doi.org/10.1016/j.arr.2022.101697.
Article CAS PubMed Google Scholar
Han D, Gong H, Wei Y, et al. Hesperidin inhibits lung fibroblast senescence via IL-6/STAT3 signaling pathway to suppress pulmonary fibrosis. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2023;112:154680. https://doi.org/10.1016/j.phymed.2023.154680.
Marek-Jozefowicz L, Czajkowski R, Borkowska A, et al. The brain-skin axis in psoriasis-psychological, psychiatric, hormonal, and dermatological aspects. Int J Mol Sci. 2022;23(2). https://doi.org/10.3390/ijms23020669.
Tohid H, Shenefelt PD, Burney WA, Aqeel N. Psychodermatology: an association of primary psychiatric disorders with skin. Rev Colomb Psiquiatr (Engl Ed). 2019;48(1):50–7. https://doi.org/10.1016/j.rcp.2017.07.002.
Molla A, Jannadi R, Alayoubi H, Altouri H, Balkhair M, Hafez D. Assessing the relationship between vitiligo and major depressive disorder severity: Cross-Sectional study. JMIR Dermatol. 2024;7:e60686. https://doi.org/10.2196/60686.
Article PubMed PubMed Central Google Scholar
Roohi E, Jaafari N, Hashemian F. On inflammatory hypothesis of depression: what is the role of IL-6 in the middle of the chaos? J Neuroinflamm. 2021;18(1):45. https://doi.org/10.1186/s12974-021-02100-7.
Kelly KM, Smith JA, Mezuk B. Depression and interleukin-6 signaling: a Mendelian randomization study. Brain Behav Immun. 2021;95:106–14. https://doi.org/10.1016/j.bbi.2021.02.019.
Comments (0)